138 related articles for article (PubMed ID: 22202598)
1. CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients.
Baumhoer D; Elsner M; Smida J; Zillmer S; Rauser S; Schoene C; Balluff B; Bielack S; Jundt G; Walch A; Nathrath M
Oncotarget; 2011 Dec; 2(12):970-5. PubMed ID: 22202598
[TBL] [Abstract][Full Text] [Related]
2. The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.
Ludyga N; Englert S; Pflieger K; Rauser S; Braselmann H; Walch A; Auer G; Höfler H; Aubele M
Mol Cancer; 2013 Apr; 12():28. PubMed ID: 23570421
[TBL] [Abstract][Full Text] [Related]
3. Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.
He G; Zou L; Zhou L; Gao P; Qian X; Cui J
Cell Physiol Biochem; 2017; 44(3):897-906. PubMed ID: 29179181
[TBL] [Abstract][Full Text] [Related]
4. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
5. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma.
Li HG; Zhao LH; Zhang ZH; Liu JZ; Ren K; Li SY; Su ZJ
Cell Physiol Biochem; 2017; 43(5):2037-2046. PubMed ID: 29059670
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
[TBL] [Abstract][Full Text] [Related]
8. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.
Balluff B; Rauser S; Meding S; Elsner M; Schöne C; Feuchtinger A; Schuhmacher C; Novotny A; Jütting U; Maccarrone G; Sarioglu H; Ueffing M; Braselmann H; Zitzelsberger H; Schmid RM; Höfler H; Ebert MP; Walch A
Am J Pathol; 2011 Dec; 179(6):2720-9. PubMed ID: 22015459
[TBL] [Abstract][Full Text] [Related]
9. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
[TBL] [Abstract][Full Text] [Related]
10. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
11. Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.
Chen Z; Liu J; Zhang Y
Med Sci Monit; 2017 Aug; 23():3861-3868. PubMed ID: 28794404
[TBL] [Abstract][Full Text] [Related]
12. CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β‑catenin signaling pathway.
Zhang LZ; Huang LY; Huang AL; Liu JX; Yang F
Life Sci; 2018 Aug; 207():420-427. PubMed ID: 29959029
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
14. Weighted Gene Coexpression Network Analysis Identifies Cysteine-Rich Intestinal Protein 1 (CRIP1) as a Prognostic Gene Associated with Relapse in Patients with Acute Myeloid Leukemia.
Ye C; Ma S; Xia B; Zheng C
Med Sci Monit; 2019 Oct; 25():7396-7406. PubMed ID: 31577790
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
17. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma.
Stokkel MP; Linthorst MF; Borm JJ; Taminiau AH; Pauwels EK
J Cancer Res Clin Oncol; 2002 Jul; 128(7):393-9. PubMed ID: 12136254
[TBL] [Abstract][Full Text] [Related]
18. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
Liu Y; Abulimiti N; Wang C
Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
[TBL] [Abstract][Full Text] [Related]
19. High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma.
Yang Q; Chen T; Yao Z; Zhang X
World J Surg Oncol; 2020 Jan; 18(1):24. PubMed ID: 32000789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
